DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML

Clinical trial NCT07712848 · RECRUITING

Trial details

NCT number: NCT07712848
Sponsor: The Second Affiliated Hospital of Kunming Medical University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

AML (Acute Myeloid Leukemia)

Start date: 2026-04-01
Primary completion: 2026-12-01
Enrollment: 291

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.